Share Article
Open letter from nuclear industry to the EU
08 June 2020 GlobalAn open letter from the nuclear industry to EU key decision makers has been published.
As a leader within the European nuclear industry, and a keen supporter of it, Urenco is one of the signatories.
The letter stresses the important role nuclear plays in maintaining essential power supplies and the key contribution the industry can make, alongside renewables, in achieving climate change goals. Nuclear remains the largest source of low carbon electricity within the EU.
The letter also highlights how nuclear can assist with the post COVID-19 economic recovery, in relation to jobs, research and development and exports. An additional message is the indispensable role of nuclear in the medical sector – from diagnostic and therapeutic applications, to detecting and curing cancer. Urenco has been investing in this area through our expanding Stable Isotopes business.
You can read the detail of the letter here: open letter from nuclear industry
Share Article
About Urenco
Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.
With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.
We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries